Exploring quality of life in patients with and without heart failure

Cleland, 2006, A comparison of the effects of carvedilol and metoprolol on well-being, morbidity, and mortality (the patient journey) in patients with heart failure: a report from the Carvedilol or Metoprolol European Trial (COMET), J. Am. Coll. Cardiol., 47, 1603, 10.1016/j.jacc.2005.11.069

Cleland, 2006, Longer-term effects of cardiac resynchronization therapy on mortality in heart failure [the CArdiac REsynchronization-Heart Failure (CARE-HF) trial extension phase], Eur. Heart J., 27, 1928, 10.1093/eurheartj/ehl099

Krzanowski, 2000

Chatfield, 1981

Lawlor, 2004, (Mis)use of factor analysis in the study of insulin resistance syndrome, Am. J. Epidemiol., 159, 1013, 10.1093/aje/kwh150

Kim, 1978

Cleland, 2000, Eur. J. Heart Fail., 2, 123, 10.1016/S1388-9842(00)00081-7

Cleland, 2003, The EuroHeart Failure survey programme — a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis, Eur. Heart J., 24, 442, 10.1016/S0195-668X(02)00823-0

Kaiser, 1958, The varimax criterion for analytic rotation in factor analysis, Psychometrika, 23, 187, 10.1007/BF02289233

Anderson, 1956, Statistical inference in factor analysis, 5, 111

Kaiser, 1970, A second generation little jiffy, Psychometrika, 35, 401, 10.1007/BF02291817

Cronbach, 1951, Coefficient alpha and the internal structure of tests, Psychometrika, 16, 297, 10.1007/BF02310555

McKinley, 1997, Reliability and validity of a new measure of patient satisfaction with out of hours primary medical care in the United Kingdom: development of a patient questionnaire, BMJ, 314, 193, 10.1136/bmj.314.7075.193

Bosma, 1997, Low job control and risk of coronary heart disease in Whitehall II (prospective cohort) study, BMJ, 314, 558, 10.1136/bmj.314.7080.558

Rector, 2012, Patients self-assessment of their congestive heart failure: content, reliability and validity of a new measure — the Minnesota Living with Heart Failure Questionnaire, Heart Fail., 3, 198

Green, 2000, Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: a new health status measure for heart failure, J. Am. Coll. Cardiol., 35, 1245, 10.1016/S0735-1097(00)00531-3

Cleland, 2007, Prevalence of markers of heart failure in patients with atrial fibrillation and the effects of ximelagatran compared to warfarin on the incidence of morbid and fatal events: a report from the SPORTIF III and V trials, Eur. J. Heart Fail., 9, 730, 10.1016/j.ejheart.2007.01.013

1990, EuroQol — a new facility for the measurement of health-related quality of life. The EuroQol Group, Health Policy, 16, 199, 10.1016/0168-8510(90)90421-9

Herdman, 2011, Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L), Qual. Life Res., 20, 1727, 10.1007/s11136-011-9903-x

Heart Failure, 2008, Guidelines, Eur. J. Heart Fail., 2008

Rietveld, 1993

Field, 2000